AutismKB 2.0

Annotation Detail for PLIN2


View Evidences View Variants View Annotations
Basic Information Top
Gene Symbol:PLIN2 ( ADFP,ADRP,MGC10598 )
Gene Full Name: perilipin 2
Band: 9p22.1
Quick LinksEntrez ID:123; OMIM: 103195; Uniprot ID:PLIN2_HUMAN; ENSEMBL ID: ENSG00000147872; HGNC ID: 248
Relate to Another Database: SFARIGene; denovo-db
Related Pathway Information Top
No data
No data
Pathway IDPathway Name
Metabolism of lipids and lipoproteins
Pathway IDPathway Name
200172HIF-1-alpha transcription factor network
No data
No data
Related Diseases/Disorders Top
No data
Desease IDDesease Name
1894Abortion
1904Diabetes mellitus
1965Clear cell carcinoma
2007Liver tumor
2022Liver cancer
2120Rabies
No data
No data
No data
Comparative Toxicogenomics Database Top
Chemical ID Chemical Name Interaction Interaction Action Publication
C062078 1-(carboxymethylthio)tetradecane 1-(carboxymethylthio)tetradecane results in increased expression of PLIN2 mRNAincreases expression 16489205
C062078 1-(carboxymethylthio)tetradecane 1-(carboxymethylthio)tetradecane results in increased expression of PLIN2 mRNAincreases expression 16489205
C062078 1-(carboxymethylthio)tetradecane 1-(carboxymethylthio)tetradecane results in increased expression of PLIN2 proteinincreases expression 16489205
D017962 alpha-Linolenic Acid alpha-Linolenic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D017962 alpha-Linolenic Acid alpha-Linolenic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D017962 alpha-Linolenic Acid alpha-Linolenic Acid results in increased expression of PLIN2 proteinincreases expression 16489205
D016718 Arachidonic Acid Arachidonic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D016718 Arachidonic Acid Arachidonic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D016718 Arachidonic Acid Arachidonic Acid results in increased expression of PLIN2 proteinincreases expression 16489205
D001280 Atrazine Atrazine results in increased expression of PLIN2 mRNAincreases expression 18585445
C019304 ciprofibrate ciprofibrate results in increased expression of PLIN2 mRNAincreases expression 12771043
D003907 Dexamethasone [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNAaffects cotreatment|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D004041 Dietary Fats Dietary Fats results in increased expression of PLIN2 proteinincreases expression 16282640
D004052 Diethylnitrosamine Diethylnitrosamine results in increased expression of PLIN2 mRNAincreases expression 12771043
D004281 Docosahexaenoic Acids Docosahexaenoic Acids results in increased expression of PLIN2 mRNAincreases expression 16489205
D004281 Docosahexaenoic Acids Docosahexaenoic Acids results in increased expression of PLIN2 mRNAincreases expression 16489205
D004281 Docosahexaenoic Acids Docosahexaenoic Acids results in increased expression of PLIN2 proteinincreases expression 16489205
D005227 Fatty Acids Fatty Acids results in increased expression of PLIN2 mRNAincreases expression 16489205
D015056 1-Methyl-3-isobutylxanthine [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNAaffects cotreatment|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C095104 LG 100268 LG 100268 results in increased expression of PLIN2 mRNAincreases expression 16489205
C095104 LG 100268 LG 100268 results in increased expression of PLIN2 proteinincreases expression 16489205
C095104 LG 100268 Oleic Acid promotes the reaction [LG 100268 results in increased expression of PLIN2 protein]increases expression|increases reaction 16489205
D019301 Oleic Acid Oleic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D019301 Oleic Acid Oleic Acid promotes the reaction [LG 100268 results in increased expression of PLIN2 protein]increases expression|increases reaction 16489205
D019301 Oleic Acid Oleic Acid promotes the reaction [pirinixic acid results in increased expression of PLIN2 protein]increases expression|increases reaction 16489205
D019301 Oleic Acid Oleic Acid results in increased expression of PLIN2 mRNAincreases expression 16489205
D019301 Oleic Acid Oleic Acid results in increased expression of PLIN2 proteinincreases expression 16489205
C006253 pirinixic acid [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PLIN2 mRNAaffects binding|increases activity|increases expression 19710929
C006253 pirinixic acid [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PLIN2 mRNAaffects binding|increases activity|increases expression 19710929
C006253 pirinixic acid pirinixic acid results in increased expression of PLIN2 mRNAincreases expression 17932310
16489205
20059764
16282640
C006253 pirinixic acid pirinixic acid results in increased expression of PLIN2 proteinincreases expression 16489205
16282640
C006253 pirinixic acid PPARA protein affects the reaction [pirinixic acid results in increased expression of PLIN2 mRNA]affects reaction|increases expression 16489205
16282640
C006253 pirinixic acid PPARA protein affects the reaction [pirinixic acid results in increased expression of PLIN2 protein]affects reaction|increases expression 16282640
C006253 pirinixic acid PPARA protein promotes the reaction [pirinixic acid results in increased expression of PLIN2 mRNA]increases expression|increases reaction 20059764
C006253 pirinixic acid PPARGC1B protein inhibits the reaction [pirinixic acid results in increased expression of PLIN2 mRNA]decreases reaction|increases expression 17932310
C006253 pirinixic acid Oleic Acid promotes the reaction [pirinixic acid results in increased expression of PLIN2 protein]increases expression|increases reaction 16489205
C006253 pirinixic acid pirinixic acid results in increased expression of PLIN2 mRNAincreases expression 16489205
C006253 pirinixic acid pirinixic acid results in increased expression of PLIN2 proteinincreases expression 16489205
C089730 rosiglitazone [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNAaffects cotreatment|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PLIN2 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin results in decreased expression of PLIN2 mRNAdecreases expression 16054899
D014280 Triglycerides PLIN2 protein affects the secretion of Triglyceridesaffects secretion 16282640
D014635 Valproic Acid Valproic Acid results in decreased expression of PLIN2 mRNAdecreases expression 19101580
Disease ID Disease Name Direct Evidence Inference Chemical Name Inference Score Publication
MESH:D000014 Abnormalities, Drug-Induced Tetrachlorodibenzodioxin 8.1911752688 14514962 15322242
MESH:D000014 Abnormalities, Drug-Induced Valproic Acid 8.198875741
MESH:D000015 Abnormalities, Multiple Valproic Acid 3.8919490988
MESH:D055371 Acute Lung Injury pirinixic acid 3.0818653653
MESH:D000236 Adenoma Diethylnitrosamine 2.826695378 10737359
MESH:D018248 Adenoma, Liver Cell Diethylnitrosamine 17.0816434500 17162532 19052882 17620307 18056438 19061943
MESH:D018248 Adenoma, Liver Cell pirinixic acid 17.0816434500
MESH:D018248 Adenoma, Liver Cell Tetrachlorodibenzodioxin 17.0816835633
MESH:D000382 Agricultural Workers' Diseases Atrazine 4.1911874814
MESH:D000544 Alzheimer Disease rosiglitazone 2.8419621015
MESH:D000550 Amblyopia Valproic Acid 5.2017688650
MESH:D000740 Anemia Tetrachlorodibenzodioxin 2.9111748828
MESH:D000860 Anoxia Oleic Acid 5.8615090967
MESH:D001008 Anxiety Disorders Valproic Acid 3.5417497229
MESH:D001161 Arteriosclerosis Dietary Fats 3.8515238619
MESH:D001169 Arthritis, Experimental Dexamethasone 3.5117659584
MESH:D001321 Autistic Disorder Arachidonic Acid 2.4818582451
MESH:D001321 Autistic Disorder Docosahexaenoic Acids 2.4818582451
MESH:D001321 Autistic Disorder Valproic Acid 2.4818775368 19232924 18940202 18558336 17157402 18985861 16609825 20603192 17507914 15238991 18396377 19460635 18177632 18316065 17688650
MESH:D001714 Bipolar Disorder Valproic Acid 3.0517594078 20046352
MESH:D001778 Blood Coagulation Disorders pirinixic acid 8.6319483382
MESH:D001778 Blood Coagulation Disorders Tetrachlorodibenzodioxin 8.6312125929
MESH:D001836 Body Weight Changes Tetrachlorodibenzodioxin 3.7615340226
MESH:D001848 Bone Diseases, Developmental Tetrachlorodibenzodioxin 7.9315746008
MESH:D001848 Bone Diseases, Developmental Valproic Acid 7.938888407
MESH:D001943 Breast Neoplasms Dietary Fats 2.0220435547
MESH:D001943 Breast Neoplasms Diethylnitrosamine 2.0217474063
MESH:D001943 Breast Neoplasms LG 100268 2.0216818667
MESH:D001943 Breast Neoplasms Tetrachlorodibenzodioxin 2.0220435547
MESH:D002277 Carcinoma Tetrachlorodibenzodioxin 2.7616835633
MESH:D006528 Carcinoma, Hepatocellular Diethylnitrosamine 1.8416935385 19107877 19539802 19383236 17428255 19418558 17978847 16698587 18210153 18691550 3581430 20514400 18393292 16540662 20214788 20432363 18506893 20512989 3084413 16502159 10672840 17162532 19701751 18494052 18788625 16830150 19519916 21159647 16878318 11831363 17761372 18665156 16807293 16328049 19208518 10737359 20935162 18056438 17055752 16779866 17173139 18971187 16288022 18978308 19919837 20524982 16569478 20007298 19394651 20101231 19335982 20727157 20084675 19822196 18785209 16681979 19052882 19171122 17138121
MESH:D006332 Cardiomegaly Tetrachlorodibenzodioxin 2.3418850075 18670907 16120746
MESH:D002471 Cell Transformation, Neoplastic Diethylnitrosamine 2.8317174075 2727394 7505956 21159647
MESH:D002659 Child Development Disorders, Pervasive Valproic Acid 2.6920734317
MESH:D018281 Cholangiocarcinoma Diethylnitrosamine 9.2019052882
MESH:D018281 Cholangiocarcinoma Tetrachlorodibenzodioxin 9.2016835633
MESH:D002779 Cholestasis pirinixic acid 2.7919176532
MESH:D002972 Cleft Palate Tetrachlorodibenzodioxin 2.0815340226 8697196 16354765 15668235 12621046
MESH:D003110 Colonic Neoplasms Dexamethasone 2.4915824018
MESH:D000013 Congenital Abnormalities Tetrachlorodibenzodioxin 3.0217141729 14669216
MESH:D019465 Craniofacial Abnormalities Dexamethasone 3.8017728286
MESH:D019465 Craniofacial Abnormalities Tetrachlorodibenzodioxin 3.8010048152 20055451 15322242
MESH:D019465 Craniofacial Abnormalities Valproic Acid 3.8017688650 8888407 16575769
MESH:D003550 Cystic Fibrosis Docosahexaenoic Acids 4.6319747007
MESH:D017449 Dermatitis, Allergic Contact Dexamethasone 3.3712438553
MESH:D003876 Dermatitis, Atopic pirinixic acid 2.4018249437
MESH:D003920 Diabetes Mellitus rosiglitazone 4.2617446233
MESH:D003924 Diabetes Mellitus, Type 2 Diethylnitrosamine 7.1020387270
MESH:D003924 Diabetes Mellitus, Type 2 rosiglitazone 7.1012642470
MESH:D003924 Diabetes Mellitus, Type 2 Tetrachlorodibenzodioxin 7.1017107852
MESH:D003967 Diarrhea Dexamethasone 3.667237001
MESH:D056486 Drug-Induced Liver Injury Diethylnitrosamine 6.1319107877
MESH:D056486 Drug-Induced Liver Injury Tetrachlorodibenzodioxin 6.1320420201
MESH:D056486 Drug-Induced Liver Injury Valproic Acid 6.1319641884 1733752
MESH:D004362 Drug Toxicity Tetrachlorodibenzodioxin 2.7311462148
MESH:D050171 Dyslipidemias Dietary Fats 3.4218367378
MESH:D004421 Dystonia Valproic Acid 4.011851702
MESH:D004485 Eczema Dexamethasone 4.4212438553
MESH:D004487 Edema Arachidonic Acid 21.267990266 16716910 15177302 11698051 9599246 9831321
MESH:D004487 Edema Dexamethasone 21.2619703484
MESH:D004487 Edema pirinixic acid 21.2612083418
MESH:D004487 Edema rosiglitazone 21.2612083418
MESH:D004487 Edema Tetrachlorodibenzodioxin 21.2612711302 11000095
MESH:D004489 Edema, Cardiac Tetrachlorodibenzodioxin 3.8715322242 18230668 16714409
MESH:D004715 Endometriosis Tetrachlorodibenzodioxin 2.9810568697 9294722
MESH:D004831 Epilepsies, Myoclonic Valproic Acid 4.1117275665 3659116
MESH:D004828 Epilepsies, Partial Valproic Acid 3.893922381 16628512
MESH:D004827 Epilepsy Valproic Acid 2.9118234410 20417680
MESH:D004832 Epilepsy, Absence Valproic Acid 3.556426943 6254150 7562514
MESH:D017029 Epilepsy, Complex Partial Valproic Acid 4.267750514
MESH:D004830 Epilepsy, Tonic-Clonic Valproic Acid 4.033659116
MESH:D004931 Esophageal Achalasia Diethylnitrosamine 5.0916302075
MESH:D005124 Eye Abnormalities Tetrachlorodibenzodioxin 2.9811564622
MESH:D005234 Fatty Liver Dietary Fats 24.2419004024 17967931 18296743 19551842
MESH:D005234 Fatty Liver Diethylnitrosamine 24.2421071580 20387270
MESH:D005234 Fatty Liver pirinixic acid 24.2419236843 20131406
MESH:D005234 Fatty Liver rosiglitazone 24.2419196556
MESH:D005234 Fatty Liver Valproic Acid 24.2414986274 19224547
MESH:D005313 Fetal Death Tetrachlorodibenzodioxin 3.4211858732
MESH:D005315 Fetal Diseases Valproic Acid 4.8616575769
MESH:D005317 Fetal Growth Retardation Valproic Acid 4.098888407 18558336
MESH:D005334 Fever Arachidonic Acid 4.6211852909
MESH:D005355 Fibrosis Dietary Fats 8.4918296743
MESH:D005355 Fibrosis Tetrachlorodibenzodioxin 8.4920067830
MESH:D006058 Gonadal Disorders Tetrachlorodibenzodioxin 4.5710696789
MESH:D006330 Heart Defects, Congenital Tetrachlorodibenzodioxin 2.3111294989 10048152
MESH:D006333 Heart Failure pirinixic acid 2.5120558911
MESH:D006470 Hemorrhage Tetrachlorodibenzodioxin 3.2911000095
MESH:D006529 Hepatomegaly pirinixic acid 8.1319772884 19176532 16221962 18467677
MESH:D006529 Hepatomegaly Tetrachlorodibenzodioxin 8.1315340226 12621046 16120746
MESH:D006548 Hernia, Diaphragmatic Dexamethasone 3.057520565
MESH:D006849 Hydrocephalus Valproic Acid 4.8317688650
MESH:D006869 Hydronephrosis Tetrachlorodibenzodioxin 4.0215340226 8697196 18606429 16959395 16354765
MESH:D006930 Hyperalgesia rosiglitazone 3.8812083418
MESH:D006937 Hypercholesterolemia Dietary Fats 3.5521332399
MESH:D006943 Hyperglycemia pirinixic acid 3.1420558911
MESH:D006949 Hyperlipidemias Dietary Fats 3.5721332399
MESH:D006973 Hypertension Dexamethasone 5.2017042910
MESH:D006973 Hypertension Tetrachlorodibenzodioxin 5.2018850075 18670907
MESH:D015228 Hypertriglyceridemia Triglycerides 5.7916979400 16238453
MESH:D007077 Ileal Diseases 1-Methyl-3-isobutylxanthine 5.4118306037
MESH:D007248 Infertility, Male Atrazine 3.6812948887
MESH:D007249 Inflammation Arachidonic Acid 19.7015177302 17371808 9831321
MESH:D007249 Inflammation Dexamethasone 19.708960868 11099482
MESH:D007249 Inflammation Dietary Fats 19.7020412841
MESH:D007249 Inflammation Diethylnitrosamine 19.7018785209
MESH:D007249 Inflammation rosiglitazone 19.7012083418
MESH:D007249 Inflammation Tetrachlorodibenzodioxin 19.7012878042 12200463
MESH:D007333 Insulin Resistance Dietary Fats 12.2411836018 18457598
MESH:D007333 Insulin Resistance pirinixic acid 12.2416306350
MESH:D007333 Insulin Resistance rosiglitazone 12.2416306350
MESH:D007569 Jaw Abnormalities Tetrachlorodibenzodioxin 3.2916580747
MESH:D007579 Jejunal Diseases 1-Methyl-3-isobutylxanthine 5.4118306037
MESH:D015459 Leukemia-Lymphoma, Adult T-Cell Docosahexaenoic Acids 4.9617077332
MESH:D015470 Leukemia, Myeloid, Acute Valproic Acid 2.1417596541 16294345
MESH:D008103 Liver Cirrhosis Dietary Fats 6.5518296743
MESH:D008103 Liver Cirrhosis Diethylnitrosamine 6.5520032147 18407596 18522880 19638242 18665156
MESH:D008106 Liver Cirrhosis, Experimental Dexamethasone 4.9416718785
MESH:D008106 Liver Cirrhosis, Experimental pirinixic acid 4.9415474484
MESH:D008106 Liver Cirrhosis, Experimental rosiglitazone 4.9415980055 17347453
MESH:D008106 Liver Cirrhosis, Experimental Tetrachlorodibenzodioxin 4.9412878042
MESH:D008107 Liver Diseases Diethylnitrosamine 4.5217034775
MESH:D008107 Liver Diseases Docosahexaenoic Acids 4.5217056761
MESH:D008113 Liver Neoplasms ciprofibrate 10.6012771043
MESH:D008113 Liver Neoplasms Diethylnitrosamine 10.6012112319 2862719 19256749 19850985 18644402 19073162 18648771 20583210 20492335 19996281 20101389 21167192 21278145 19294768 20405173 20434301 19426721 20118626 19499222 16942905 19638242 2422723 19812893 19427195 18977376 19551842 9163691 18978307 19254457 15885732 12771043 19090486 20137499 21071580 19833225 19642983 15175105 19255062 21047994 20501860 18754104 19690152 20452335 10737359
MESH:D008113 Liver Neoplasms pirinixic acid 10.6015890375 20007298 16377806
MESH:D008113 Liver Neoplasms Tetrachlorodibenzodioxin 10.6016984957
MESH:D008114 Liver Neoplasms, Experimental Diethylnitrosamine 5.6718308698 18775883 2563599 19009564 19126423 18544905 21159647 3124819 18093689 19539802 16842330 18079962 18282651 16267830 9362446 17942915 19004024 18253720 18164116 19519916 17174075 17854601
MESH:D008114 Liver Neoplasms, Experimental Tetrachlorodibenzodioxin 5.6712151625
MESH:D017563 Lung Diseases, Interstitial Valproic Acid 4.2317228818
MESH:D055370 Lung Injury Oleic Acid 5.3115090967
MESH:D008175 Lung Neoplasms Dexamethasone 3.4115824018 11195469
MESH:D008175 Lung Neoplasms Diethylnitrosamine 3.416695378 21163286 20512841 20970405
MESH:D008175 Lung Neoplasms Tetrachlorodibenzodioxin 3.4119555203 11884234
MESH:D008325 Mammary Neoplasms, Experimental LG 100268 6.9212374698
MESH:D008325 Mammary Neoplasms, Experimental rosiglitazone 6.9216827153
MESH:D008654 Mesothelioma Atrazine 3.511916698
MESH:D024821 Metabolic Syndrome X rosiglitazone 4.3417261469
MESH:D008881 Migraine Disorders Valproic Acid 3.1618803445 18765137
MESH:D009101 Multiple Myeloma Dexamethasone 3.4715867202 15744524 16118317
MESH:D009135 Muscular Diseases pirinixic acid 3.4716239165
MESH:D009139 Musculoskeletal Abnormalities Valproic Acid 3.998888407
MESH:D009190 Myelodysplastic Syndromes Dexamethasone 7.489809623
MESH:D009190 Myelodysplastic Syndromes Valproic Acid 7.4817596541
MESH:D009203 Myocardial Infarction pirinixic acid 2.1219151258
MESH:D017202 Myocardial Ischemia Tetrachlorodibenzodioxin 2.9812213967
MESH:D015428 Myocardial Reperfusion Injury pirinixic acid 2.9116411023
MESH:D009362 Neoplasm Metastasis Diethylnitrosamine 2.553581430 9029167
MESH:D009369 Neoplasms pirinixic acid 1.9317405874
MESH:D009421 Nervous System Malformations Tetrachlorodibenzodioxin 3.1714600291
MESH:D009436 Neural Tube Defects Valproic Acid 3.108888407 16359493
MESH:D019636 Neurodegenerative Diseases Diethylnitrosamine 3.3020387270
MESH:D009461 Neurologic Manifestations Diethylnitrosamine 5.0920387270
MESH:D009765 Obesity Dietary Fats 4.4011836018 19632207 18457598 18674790 20518802 21332399 16723640 17217161 20132043
MESH:D009765 Obesity pirinixic acid 4.4020558911
MESH:D010190 Pancreatic Neoplasms Diethylnitrosamine 2.4116540662
MESH:D010300 Parkinson Disease Atrazine 3.2617218051
MESH:D010382 Peliosis Hepatis Tetrachlorodibenzodioxin 4.2212520081
MESH:D017119 Porphyria Cutanea Tarda Tetrachlorodibenzodioxin 3.5218163543
MESH:D011230 Precancerous Conditions Diethylnitrosamine 3.512563599
MESH:D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma Dexamethasone 3.5221297632
MESH:D011297 Prenatal Exposure Delayed Effects Tetrachlorodibenzodioxin 9.3511399792 11896295 11118676 11222880
MESH:D011297 Prenatal Exposure Delayed Effects Valproic Acid 9.3520603192
MESH:D019310 Pseudolymphoma Valproic Acid 4.5112752131 11422049
MESH:D011654 Pulmonary Edema Oleic Acid 5.7715090967
MESH:D015427 Reperfusion Injury pirinixic acid 2.3619058328
MESH:D012128 Respiratory Distress Syndrome, Adult Dexamethasone 9.6618379247 11700416
MESH:D012128 Respiratory Distress Syndrome, Adult Oleic Acid 9.6618549715
MESH:D012135 Respiratory Sounds Atrazine 4.4811874814
MESH:D015619 Respiratory System Abnormalities Tetrachlorodibenzodioxin 3.8018990726
MESH:D012208 Rhabdomyosarcoma Valproic Acid 4.1319155313
MESH:D012559 Schizophrenia Valproic Acid 2.0619110320 15737665
MESH:D012640 Seizures Valproic Acid 2.713137016 17978042 14763951 15475178 11044598 16876388 1511512 11738929
MESH:D012878 Skin Neoplasms Tetrachlorodibenzodioxin 2.0216192470
MESH:D016135 Spinal Dysraphism Valproic Acid 3.7519490988
MESH:D013226 Status Epilepticus Valproic Acid 4.5112833885
MESH:D013272 Stomach Diseases Dexamethasone 4.2915472012
MESH:D013274 Stomach Neoplasms Diethylnitrosamine 2.8718456281
MESH:D013274 Stomach Neoplasms Docosahexaenoic Acids 2.8719015929
MESH:D013276 Stomach Ulcer Dexamethasone 3.4515138204
MESH:D013959 Thyroid Diseases Tetrachlorodibenzodioxin 3.8712697716
MESH:D013964 Thyroid Neoplasms Diethylnitrosamine 2.957505956
MESH:D014178 Translocation, Genetic Valproic Acid 5.2017262798
MESH:D020194 Unverricht-Lundborg Syndrome Valproic Acid 4.493119515
MESH:D014564 Urogenital Abnormalities Valproic Acid 4.608888407
MESH:D014605 Uveitis Dexamethasone 4.791336536
MESH:D054079 Vascular Malformations Tetrachlorodibenzodioxin 4.5712125929
MESH:D019282 Wasting Syndrome Tetrachlorodibenzodioxin 4.2215886252
MESH:D015430 Weight Gain Dietary Fats 3.7016723640
Pathway ID Pathway Name
REACT:22258 Metabolism of lipids and lipoproteins
Pharmacogenomics Knowledge Base Top
Drug Bank Top

Simple Query:


  (e.g. CHD8)

Syndromic Genes

Non-syndromic Genes

AutismKB Statistics

  • Studies: 1,036
  • Genes: 1,379
  • CNVs/SVs: 5,420
  • SNVs/Indels: 11,669
  • de novo Mutations: 5,669
  • Mosaics: 789
  • Linkage Regions: 172
  • Paper Collected: 6/30/2018
  • Last Update: 8/26/2018


Copyright © 2017, Center for Bioinformatics , Peking University | All Rights Reserved